首页> 外文OA文献 >Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism‐Driven Clinical Trials

【2h】

Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism‐Driven Clinical Trials

机译：综合基因组分析促进了肺癌生物标志物检测的全国综合癌症网络准则，并确定可能从机制驱动的临床试验中获益的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
James H. Suh; Adrienne Johnson; Lee Albacker; Kai Wang; Juliann Chmielecki; Garrett Frampton; Laurie Gay; Julia A. Elvin; Jo‐Anne Vergilio; Siraj Ali; Vincent A. Miller; Philip J. Stephens; Jeffrey S. Ross;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials [J] . Suh James H., Johnson Adrienne, Albacker Lee, The oncologist . 2016,第6期

机译：全面的基因组分析有助于实施《国家综合癌症网络》关于肺癌生物标志物检测的指南，并确定可从参与机制驱动的临床试验中受益的患者
2. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials [J] . James H. Suh, Adrienne Johnson, Lee Albacker, The oncologist . 2016,第6期

机译：全面的基因组分析有助于实施《国家综合癌症网络》关于肺癌生物标志物检测的指南，并确定可从参与机制驱动的临床试验中受益的患者
3. Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancers [J] . Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第15期

机译：综合无细胞DNA分析鉴定新诊断的转移性非小细胞肺癌患者基因组生物标志物的临床效用
4. Machine Learning-powered Prediction of Recurrence in Patients with Non-small Cell Lung Cancer Using Quantitative Clinical and Radiomic Biomarkers [C] . Sehwa Moon, Dahim Choi, Ji-Yeon Lee, Medical Imaging Conference . 2020

机译：使用定量学习和放射生物标志物的机器学习技术预测非小细胞肺癌患者的复发
5. Assessing North Dakota nurse practitioners' knowledge of the National Comprehensive Cancer Network's treatment guidelines for adult cancer pain. [D] . Schoenberg, Lisa Marie. 2013

机译：评估北达科他州的护士从业人员对国家综合癌症网络对成人癌症疼痛的治疗指南的了解。
6. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials [O] . James H. Suh, Adrienne Johnson, Lee Albacker, 2016

机译：全面的基因组分析有助于实施国家综合癌症网络关于肺癌生物标志物检测的指南并确定哪些患者可能会因参与机制驱动的临床试验而受益
7. Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer [O] . Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, 2019

机译：综合无细胞DNA分析的临床效用，以鉴定新诊断的转移性非小细胞肺癌患者基因组生物标志物

Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism‐Driven Clinical Trials

著录项

相似文献

相关主题

期刊订阅